We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Benchmark Holdings Plc | LSE:BMK | London | Ordinary Share | GB00BGHPT808 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.90 | 4.31% | 46.00 | 45.20 | 46.00 | 45.90 | 45.90 | 45.90 | 18,774 | 16:35:10 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 169.74M | -23.15M | -0.0313 | -14.66 | 339.36M |
TIDMBMK
RNS Number : 4452O
Benchmark Holdings PLC
29 January 2019
29 January 2019
BENCHMARK HOLDINGS PLC
("Benchmark" or the "Company")
Posting of Annual Report & Accounts and Notice of AGM
Benchmark (AIM: BMK), the aquaculture health, nutrition and genetics business, announces that its Annual Report and Accounts for the year ended 30 September 2018 and the notice of the 2019 Annual General Meeting ("AGM") and related form of proxy have been posted to shareholders.
The AGM will be held on 14 March 2019 at 12:00pm at Travers Smith LLP, 10 Snow Hill, London, EC1A 2AL.
An electronic copy of the Annual Report and Accounts is available in the Investor Relations section of the Company's website, www.benchmarkplc.com/investors/
Enquiries
For further information, please contact:
Benchmark Holdings plc Tel: 020 3915 1236
Malcolm Pye, CEO
Ivonne Cantu, Investor Relations Director
Numis Tel: 020 7260 1000
Michael Meade / Freddie Barnfield (NOMAD)
James Black (Corporate Broking)
MHP Tel: 020 3128 8742
Katie Hunt / Reg Hoare /Alistair de Kare-Silver benchmark@mphc.com
Notes to Editors:
Benchmark's mission is to drive sustainability in food production. We are a leading provider of aquaculture solutions in genetics, health and specialist nutrition. Our focus is on developing innovative products that help fish and shrimp producers improve their sustainability and profitability by improving yield, quality, health and welfare. Our main products are salmon eggs with superior genetic traits, specialist nutrition products for shrimp and fish, and health treatments including a sea lice treatment for salmon. We serve all the major aquaculture markets around the world and have leading market positions. Benchmark operates in 27 countries, employs 1,066 people and reported revenues of GBP151.5m in FY 2018.
For further information on Benchmark please visit www.benchmarkplc.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
ACSPGUGUGUPBGAB
(END) Dow Jones Newswires
January 29, 2019 10:07 ET (15:07 GMT)
1 Year Benchmark Chart |
1 Month Benchmark Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions